Stucture (Image 01)
Zoledronic Acid Injection, Solution
Product Images NDC 67457-794
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 67457-794). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Image 02)
This appears to be a graph depicting therapeutic response over time for two different treatments, Zoledronic Acid and Risedronate, as measured by Response Rate (%), represented on the y-axis. The x-axis depicts the time in days, and the graph shows a significant improvement in response rate for both treatments over time. There is also a second graph indicating serum alkaline phosphatase (SAP) normalization rate over time, represented by a line graph. The same two treatments, Zoledronic Acid and Risedronate, are compared and show a significant improvement in SAP normalization rate over time as well.*
Pouch Label (Image 03)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
